In vitro and in silico characterization of a novel glutamate carboxypeptidase from Cohnella sp. A01

Seyed Mahdi Naeemi1, Saeed Aminzadeh2, Soyar Sari1

  • 1Department of Molecular and Cellular Sciences, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Biochimie
|December 9, 2022
PubMed

Insights

A novel bacterial enzyme, recombinant glutamate carboxypeptidase (rCP302), efficiently degrades folic acid. Its stability and characteristics suggest potential pharmaceutical applications.

Area of Science:

  • Biochemistry
  • Enzymology
  • Structural Biology

Background:

  • Glutamate carboxypeptidase is a bacterial metallopeptidase.
  • It hydrolyzes glutamate residues from the C-terminus of folic acid.

Purpose of the Study:

  • To evaluate the heterologous production, purification, and characterization of a novel zinc-dependent glutamate carboxypeptidase (rCP302) from Cohnella sp. A01.
  • To analyze its activity, structure, and stability under various conditions.
  • To compare rCP302 with related enzymes.

Main Methods:

  • Bioinformatic analysis for enzyme family classification.
  • Heterologous production and purification.
  • Enzyme activity assays at varying temperatures and pH.
  • Fluorescence spectroscopy for structural elucidation.
  • Kinetic parameter determination (Km, specific activity).
  • Enzyme inhibition studies using EDTA.
  • Half-life determination at different temperatures.

Main Results:

  • rCP302 showed maximum similarity to the M20 family of metallopeptidases.
  • Purified enzyme molecular weight was approximately 41.6 kDa.
  • Optimal activity observed at 50°C and pH 7.2.
  • Km and specific activity for folate were 0.108 μM and 687 μmol/min/mg, respectively.
  • Enzyme activity was inhibited by zinc ion chelation with EDTA.
  • rCP302 exhibited a long half-life (2012 min at 30°C).

Conclusions:

  • rCP302 is a stable, zinc-dependent glutamate carboxypeptidase with high catalytic efficiency.
  • Its favorable characteristics, including stability at mammalian physiological temperatures, warrant further investigation for pharmaceutical applications, particularly in folic acid metabolism modulation.

Related Concept Videos